Cancer is a ticking time bomb globally. Every year about 18 million women and men are diagnosed with various cancers including carcinomas, sarcomas, neuroendocrine tumors, melanomas. These cancers are also associated with about 9 million deaths. This translates into roughly 34 cancer cases being detected and 18 cancer related deaths every minute. Annually, these cancers contribute to:
~4.1 million newly diagnosed cases and 1.8 million deaths in Europe (including the UK).
~2.1 million newly diagnosed cases and 550,000 deaths in the US.
~1.2 million newly diagnosed cases and 760,000 deaths in India.
Due to changes in lifestyle as well as other risk factors, these numbers are stated to increase in the future. Detecting cancer early is vital to saving lives. Studies have shown that early detection of cancer improves survival rates.
Trucheck™ is a blood test that can enable early detection of multiple cancers in asymptomatic individuals.
Screening programmes are effective for some but not all cancer types and in general are far more complex and resource-intensive than early diagnosis as they require special equipment and dedicated personnel. Getting screening tests regularly may find breast, cervical, and colorectal (colon) cancers early, when treatment is likely to work best. Patient selection for screening programmes is based on age and risk factors to avoid excessive false positive studies.
Trucheck™ is a blood test that can enable early detection of multiple cancers in asymptomatic individuals. Trucheck™ is intended to be performed annually as a routine test.
